Share
Client and project overview
- A leading data and analytics company engaged us to perform commercial due diligence (CDD) on a provider of consumer verification, credit, and fraud risk solutions
- We worked on an undisclosed basis to assess the sustainability of the target’s business model and to validate its deal value
Key questions
- What is the target’s position within the competitive landscape for credit risk assessment and for fraud analytics?
- To what extent does the target meet the key purchasing criteria of its existing and potential customers?
- What is the customer perception of the target and its products?
- What are the underlying growth drivers, risks, and regulatory hurdles in the target market?
Our methodology
- To find the answers, we organized an extensive interview program of executives, both market experts and customers, across the Fintech, Credit Card, and Telecom verticals (e.g., LendingClub, American Express, T-Mobile, Verizon)
- We also gauged the target’s financial health with a detailed revenue assessment
Results
- We assessed the target as occupying an established and strong market position and provided recommendations for finetuning its go-to-market strategy
- In light of our work, our client decided to acquire the target company.
Read More
Rob Larson was featured by Bezinga, offering his expert insights on the current state of healthcare within PE and why investments continue to be made in the industry, Read more.
Partner Chen Liu attended CivStart's GovTech conference, sharing his insights and key takeaways on what GovTech providers and investors should know. Read more.
Grant Thornton Stax has released its annual Top 20 Ranking of Exhibition Organizers. Click here to explore the full list.
Global Practice Leader Paul Edwards explains how diligence is changing and how confidence and conviction are adding exit value. Read the full article here.
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
Grant Thornton Stax supported Outcomes, a leading provider of clinical network services and pharmacy technology, on its recent acquisition by H.I.G. Capital. Read more.